Correlation Between Estrella Immunopharma and Unicharm Corp
Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Unicharm Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Unicharm Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Estrella Immunopharma and Unicharm Corp, you can compare the effects of market volatilities on Estrella Immunopharma and Unicharm Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Unicharm Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Unicharm Corp.
Diversification Opportunities for Estrella Immunopharma and Unicharm Corp
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Estrella and Unicharm is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Unicharm Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicharm Corp and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Unicharm Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicharm Corp has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Unicharm Corp go up and down completely randomly.
Pair Corralation between Estrella Immunopharma and Unicharm Corp
Assuming the 90 days horizon Estrella Immunopharma is expected to generate 19.97 times more return on investment than Unicharm Corp. However, Estrella Immunopharma is 19.97 times more volatile than Unicharm Corp. It trades about 0.15 of its potential returns per unit of risk. Unicharm Corp is currently generating about -0.25 per unit of risk. If you would invest 9.00 in Estrella Immunopharma on September 4, 2024 and sell it today you would earn a total of 0.10 from holding Estrella Immunopharma or generate 1.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 31.25% |
| Values | Daily Returns |
Estrella Immunopharma vs. Unicharm Corp
Performance |
| Timeline |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Good
| Unicharm Corp |
Estrella Immunopharma and Unicharm Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Estrella Immunopharma and Unicharm Corp
The main advantage of trading using opposite Estrella Immunopharma and Unicharm Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Unicharm Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicharm Corp will offset losses from the drop in Unicharm Corp's long position.| Estrella Immunopharma vs. Chewy Inc | Estrella Immunopharma vs. Anheuser Busch Inbev | Estrella Immunopharma vs. Simon Property Group | Estrella Immunopharma vs. Revolve Group LLC |
| Unicharm Corp vs. LOreal Co ADR | Unicharm Corp vs. Unilever PLC ADR | Unicharm Corp vs. Kimberly Clark | Unicharm Corp vs. The Clorox |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |